MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Edwards Lifesciences Corporation Depreciation & Amortization 2011-2026 | EW
Annual Depreciation & Amortization Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 155 M | 145 M | 140 M | 135 M | 107 M | 89.3 M | 77.4 M | 81.9 M | 71.2 M | 65.8 M | 68.6 M | 62.9 M | 53.7 M | 58 M | 56.5 M | 58.7 M | 55.6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | 53.7 M | 91 M |
Quarterly Depreciation & Amortization Edwards Lifesciences Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.9 M | - | - | 36.6 M | - | - | - | 38.5 M | - | - | - | 35.2 M | - | 104 M | - | 34.7 M | - | 102 M | - | 32.4 M | - | 74.6 M | 49 M | 24.5 M | - | 65.4 M | 42.3 M | 20.6 M | - | 57.5 M | 38.3 M | 19.1 M | - | 60.7 M | 40 M | 21.1 M | - | 52.1 M | 33.9 M | 15.9 M | - | 51.3 M | 32.8 M | 16 M | - | 50.3 M | 32.3 M | 16.2 M | - | 45.8 M | 28.8 M | 14.1 M | - | 42.2 M | 27.8 M | 13.8 M | - | 43.2 M | 29.3 M | 14.5 M | 41.1 M | 27.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 13.8 M | 39.2 M |
Depreciation & Amortization of other stocks in the Medical devices industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
2.56 M | $ 4.1 | -4.87 % | $ 154 M |  France |
 |
Avinger
AVGR
|
289 K | - | -20.74 % | $ 369 K |  USA |
 |
Axonics Modulation Technologies
AXNX
|
12.5 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
5.46 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
451 K | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
814 K | $ 11.44 | -3.21 % | $ 324 M | USA |
 |
Apollo Endosurgery
APEN
|
1.21 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
77.5 M | $ 7.78 | -3.54 % | $ 1.17 B | USA |
 |
Aziyo Biologics
AZYO
|
2.78 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
3.53 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
2.8 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
4.03 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
3.69 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
3.58 M | $ 5.9 | -2.48 % | $ 70.6 M | USA |
 |
Helius Medical Technologies
HSDT
|
36 K | $ 2.23 | -3.04 % | $ 49.2 M | USA |
 |
IRIDEX Corporation
IRIX
|
523 K | $ 1.04 | - | $ 17.6 M | USA |
 |
Pulmonx Corporation
LUNG
|
1.1 M | $ 1.54 | -2.23 % | $ 62.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
1.23 M | $ 0.48 | 4.37 % | $ 29.9 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
21.1 M | $ 17.57 | -1.87 % | $ 412 M | USA |
 |
Delcath Systems
DCTH
|
238 K | $ 11.02 | 1.75 % | $ 395 M | USA |
 |
Myomo
MYO
|
859 K | $ 0.99 | -3.32 % | $ 41.4 M | USA |
 |
LivaNova PLC
LIVN
|
28.6 M | $ 73.07 | -3.12 % | $ 3.99 B |  Britain |
 |
Orthofix Medical
OFIX
|
77.3 M | $ 9.4 | -3.84 % | $ 372 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
487 K | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
14.9 M | $ 3.59 | -2.32 % | $ 531 M | USA |
 |
Profound Medical Corp.
PROF
|
373 K | $ 6.93 | 2.36 % | $ 210 M |  Canada |
 |
Electromed
ELMD
|
1.04 M | $ 37.88 | -1.1 % | $ 320 M | USA |
 |
Butterfly Network
BFLY
|
6.7 M | $ 4.59 | 0.77 % | $ 1.13 B | USA |
 |
Second Sight Medical Products
EYES
|
424 K | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
319 K | $ 2.35 | -3.29 % | $ 6.52 M | USA |
 |
GBS
GBS
|
970 K | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
277 M | $ 82.8 | -2.7 % | $ 11.2 B | USA |
 |
Insulet Corporation
PODD
|
90.4 M | $ 145.28 | -5.54 % | $ 10.2 B | USA |
 |
CONMED Corporation
CNMD
|
17.1 M | $ 35.66 | -1.11 % | $ 1.11 B | USA |
 |
Inspire Medical Systems
INSP
|
14 M | $ 42.0 | 0.02 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
131 M | $ 88.64 | -1.66 % | $ 3.08 B | USA |
 |
Invacare Corporation
IVC
|
15.5 M | - | - | $ 24.7 M | USA |
 |
TransMedics Group
TMDX
|
27.2 M | $ 68.98 | -2.1 % | $ 2.34 B | USA |